We present a Focused Library Generator that is able to create from scratch new molecules with desired properties. After training the Generator on the ChEMBL database, transfer learning was used to switch the generator to producing new Mdmx inhibitors that are a promising class of anticancer drugs. Lilly medicinal chemistry filters, molecular docking, and a QSAR IC 50 model were used to refine the output of the Generator. Pharmacophore screening and molecular dynamics (MD) simulations were then used to further select putative ligands. Finally, we identified five promising hits with equivalent or even better predicted binding free energies and IC 50 values than known Mdmx inhibitors. The source code of the project is available on https ://githu b.com/bigch em/onlin e-chem.
Introduction
To find molecules that maximize the desirable properties and simultaneously minimize their adverse effects is a significant challenge in the modern chemically-related sciences. This is especially true for drug discovery research where a few atoms have to "encode" specific activity, selectivity, pharmacokinetics etc. The number of chemical compounds is enormous [1, 2] , with drug-like space estimated to be 10 60 molecules, and to even enumerate all of them is an impossible task much less consider synthesis and experimental testing. Several approaches-to name the most beneficial, virtual screening, and in silico structure generation-have been developed to enrich the outcome of projects involved in designing new molecules with optimized properties. The former approaches (filters) screen a database of existing organic compounds (e.g. the ZINC database), or just synthesizable (Enamine REAL [3] ), against several prognostic models built within QSAR/QSPR (Quantitative Structure-Activity/Property Relationship) methodology, and select the most promising candidates for further analysis and experimental testing. The latter strategies (generators) can computationally generate new molecules [4] with desired predicted properties using experimentally validated training sets [5] . Such molecules can be later produced and assayed. The main advantage of the latter procedures is that they can potentially navigate in unexplored areas of chemical space not represented in existing libraries. Such compounds offer potentially better specificity, selectivity, and pharmacokinetic properties. They are also unlikely to be covered by existing intellectual property limitations.
The generators are based on the recent progress with sequence data processing methods. Examples of such data are natural language sentences or music where each subsequent piece of information (words or notes) depends on the previous parts. Since the first work on sequence generation revealed the possibility for recurrent neural networks to model the probability distribution of the next token in a sequence [6] , the scientific community immediately realized its power and opportunities. Many works appeared in different data domains, including among others, chemoinformatics [4] . The chemical molecules can be presented as ordinary alphanumeric strings by means of Simplified Molecular Input Line Entry System (SMILES) [7] from which the model can learn the conditional probability distribution of the next symbol with respect to all previous tokens. Once trained, the model can generate a new and diverse set of valid SMILES that are similar to the training dataset [8] . Though the ability to generate an arbitrary compound from "nothing" looks promising and appealing, its practical application is not different from exploiting combinatorial libraries. Therefore, it is crucial to find a way to adapt the model for sampling new molecules from the desired region of chemical space. For this purpose, transfer learning techniques, where the pre-trained model continues training on a task-specific dataset, are widely used [9] . After several epochs, the model converges and begins producing SMILES that are similar to such datasets. Another way to restrict molecular generator is to apply a reinforcement learning paradigm and bias selection of symbols from high probability variants drawn from the predicted distribution [5, 10] . Recurrent neural network architecture shows exceptionally good performance in sequence-related tasks. During sequence processing, the network stores the entire "idea" of the input data in its internal state. This encoding vector can be successfully converted to new SMILES by using it as the starting internal state of another recurrent unit. Thus, other techniques, for example, Generative Adversarial Networks (GAN) [11, 12] , and Variational Autoencoders [13] , can efficiently navigate in this encoding space and enforce the recurrent network to produce focused SMILES of interest.
In our work we demonstrated the applicability of such approaches to model the mouse double minute x (Mdmx, also known as Mdm4), which is a critical negative regulator of a tumor suppressor protein p53 [14] . Mdmx triggered a wave of research since the discovery of its importance to cancer progression [15] . The mutation of TP53 appears in about half of human cancers [16] , and in the remnant, the wild-type p53 is inactivated by its negative regulators, Mdm2 and Mdmx proteins [17] . The former is the first experimentally identified as a major endogenous inhibitor of p53 [18] [19] [20] , and the latter, which is highly homologous with Mdm2, influences p53 transcriptional activity [14] and is a vital independent regulator of p53 [21] . Until now, however, the studies on small-molecule Mdmx inhibitors have made slow progress. There are nine Mdm2 inhibitors in clinical studies [22, 23] , but for Mdmx, there is none. Development of SJ-172550, the first reported inhibitor of Mdmx [24] , was put on hold because of stability problems [25] , other alternatives, like XI-011 [26] , and NSC207895 [27] had difficulties at the preclinical trials.
Even though Mdm2 and Mdmx are structurally closely related, their slight differences lead to Mdm2 inhibitors or even p53 transactivation domain being inferior in terms of binding affinity to Mdmx [28] . The usage of Mdm2 inhibitors in some cases is significantly limited due to its toxicity in normal cells [29] . Recently, it was reported that the loss of Mdmx induces p53 activation but has much less destructive effects in vivo than Mdm2 inhibition [30] . Therefore, Mdmx remains an interesting and unexplored target of great potential for cancer treatment.
For the first time, we applied generative neural networks for designing new putative Mdmx inhibitors in silico and validated our approach with MD calculations. We showed that the Generator equipped with appropriate constraints, e.g. molecular docking, and a QSAR regression model, can efficiently navigate in chemical space with a high density of promising inhibitors. The overall methodology, as well as the source code provided (https ://githu b.com/bigch em/ onlin e-chem), can be applied to other drug-design projects with minor changes.
Methods

Datasets
ChEMBL library of SMILES
For our primary generator model we selected 1,727,112 compounds from the ChEMBL library [31] . As distinct from all other works on SMILES generators, we did not perform a pre-processing of the original data, e.g., string size limitation, chirality removing, standardization, and chemistryrelevant tokenization. This was done with a goal of training a universal recurrent model that would be able to cover the whole ChEMBL database and then, finding weights ("embedding") that could also be used separately from the original generator model. This SMILES-embedding, like word-embeddings which are actively used for construction of language models, could be also applied to QSAR modeling [32] . 77,112 randomly selected SMILES were used as a validation set while the remaining 1,650,000 SMILES were used as a training set.
Mdmx inhibitors
The training set of inhibitors (total 293) with experimental IC 50 values [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] , which have been tested with human Mdmx, were selected from the ChEMBL and BindingDB [45] databases. Their IC 50 values were measured by several kinds of methods, such as the enzyme-linked immunosorbent assay (ELISA) (21 compounds), the dose-response confirmation of Inhibitors of Mdm2/MdmX interaction in luminescent format (19 compounds), the time resolved fluorescence energy transfer (TR-FRET) assay (237 compounds), fluorescence polarization assay (FPA) (2 compounds), the quantitative sandwich immune-enzymatic assay (14 compounds ). Most of the inhibitors had log (IC 50 ) values less than − 4.0, Fig. 1 .
The average Tanimoto similarity within the dataset is 0.56. One can cluster all compounds in three different scaffolds, Table. 1, though only one cluster contains the majority of inhibitors (247 compounds).
SMILES generator neural network (SGNN)
The generator neural network model consists of 2 Long-Short Term Memory (LSTM) [46] layers stacked upon each other with the number of internal units equal to 512 and hyperbolic tangent as a nonlinearity activation function. Stacked recurrent layers are commonly used for generator architectures but vary in the number of layers and the number of processing units in each layer, Table 2 .
The last model in Table 2 contains the smallest number of layers. We chose this architecture but with a bigger number of units equal to 512, which resulted in 3,306,043 parameters. SGNN vocabulary is bigger (stereochemistry and inorganic ions) than in [48] , so more training parameters are needed to encode the information. Following the [48] last LSTM layer, we added an ordinary dense layer with a softmax output, Fig. 2 . To facilitate batch computation, we applied masking to differentiate which positions in the input sequence are valid symbols. By design, our model can work with batches of different lengths, also consisting of strings of various sizes. The input vocabulary was fixed to 66 letters including characters for the start (^) and the end ($) of a string $#%()+-./0123456789=@ABCFGHIKLMNOPRST-VXZ[\]abcdegilnoprstuB esides drug-like compounds, the proposed vocabulary can additionally encode inorganic ions often co-crystallized with the core fragment. It also can work with common reagents in organic synthesis, thus, facilitating the use of the same molecular representation in different models, being a universal SGNN model.
Each letter was one-hot encoded and then passed to recurrent units. We did not employ any tokenization scheme for the SMILES generation model because, as stated above, the primary goal was to train a universal model covering the whole ChEMBL database. Therefore, any restriction, even if it may seem chemistry-relevant, could lead to an under-representation of some classes of tokens in the training dataset, thus, worsening the quality of the entire model. Our preliminary analysis showed that using the popular tokenization scheme [49] over simple character-based treatment did not improve the accuracy of the model. The output of the SGNN is a probability distribution of the next symbol conditioned on all previous symbols in a string over the vocabulary. During decoding, we randomly pick a symbol from the vocabulary according to this distribution. Sampling at higher temperatures results in a smoother probability landscape and, therefore, can produce more diverse but also invalid SMILES. To adjust the softmax output to different temperatures, the following formula is used (see details in Supporting Information):
where y i is the output of the SGNN, T is the temperature, and p i is the corrected probability.
The SGNN was implemented in Lasagne [50] with Theano backend [51] . SMILES validation was done using RDKit library [52] . SGNN was trained for 100 epochs with the Adagrad optimization algorithm [53] (constant learning rate 0.01, gradient clipping 100, batch size 2048). To avoid overfitting, we used the early-stopping technique with a validation dataset. However, we did not see the overfitting and stopped training after the maximum number of epochs.
Molecular docking
The crystal structure of Mdmx in complex with p53 (PDB ID: 3dab [54] ) at a resolution of 1.9 Å was used for the docking studies. The receptor was protonated at neutral pH with only polar hydrogens by AutoDockTools-1.5.6 and Gasteiger charges were added. By centering on p53, the docking grid was created. In particular, a grid box size of 24 × 18 × 22 and centered at 0.514 (x), -21.838 (y), and 8.047 (z) was set with spacing of 1.0 Å between the grid points. The ligands were docked using the AutoDock VINA [55] program (hereafter simply called VINA). Ten predicted conformations were generated for each ligand. The rest of the parameters were set to the default values. From the 10 binding poses, we chose the optimal one in terms of the docking score.
QSAR models for IC 50 and solubility estimation
To estimate IC 50 values of new Mdmx inhibitors we built a regression model using the OCHEM platform. OCHEM platform [56] automatically estimates the applicability domain (AD) [57] that is of crucial need for the current project. The generator treats molecules as simple sequences of characters with predefined grammar rules. Though the final sequence may be a valid SMILES, it can result in a molecule, which is chemically non-synthesizable or is very different from the training set for which IC 50 estimation may be unreliable. The QSAR model was used for additional filtering of the generated compounds selecting only those molecules that are in its AD. We explored different machine learning methods and descriptors available on OCHEM website and found that the best model was based on a Transformer-CNN method [58] . This model's parameters are coefficient of determination r 2 = 0.69, root mean squared error RMSE = 0.51, and mean absolute error MAE = 0.35 (n = 293). The model is publicly available on https ://ochem .eu/model /785. We used all 293 compounds for modeling though some values were measured with different methods because the number of points on individual assays were not enough for building and validating a model (see Datasets section). Though our primary interest was to find new molecules that can bind to Mdmx we also ran the full generation cycle with solubility as one of the constraints besides IC 50 and VINA endpoints. The solubility model used in this study was built with the same Transformer-CNN approach and resulted in r 2 = 0.92, RMSE = 0.58, and MAE = 0.41 (n = 1311) and is available on https ://ochem .eu/model /784.
Tuning the generator
After training the generator on the ChEMBL database, we tuned it with the Mdmx dataset according to the following algorithm:
Retraining the SGNN model solely on known Mdmx inhibitors, which formed the transfer set. The number of unique molecules in the transfer set was small compared to the initial ChEMBL training dataset. Therefore, we augmented (maximum 10 times) this set with non-canonical SMILES [59, 60] , which were shown to increase the accuracy of the models. For example, toluene canonical SMILES is Cc1ccccc1, and non-canonical variants are: c1cccc(C) c1, c1ccc(C)c1, c1c(cccc1)C, etc. Both canonical and noncanonical SMILES were used in the training set for the SGNN.
New SMILES were generated by SGNN. The compounds which passed a Lipinski-like filter (MW > 100 and MW < 700, HBD < 5, and HBA < 10) and a collection of Lilly filters [61] were then docked with VINA [55] . An IC 50 QSAR model was also used to estimate the IC 50 values for the molecules generated. Both docking scores and IC 50 values were saved in the temporary database.
The generated compounds were ranked by considering both IC 50 and VINA scores simultaneously. According to Fig. 1 , most active compounds have − 8 ≤ log(IC 50 ) ≤ − 4 and − 11 ≤ VINA score ≤ − 8. The Spearman correlation coefficient between VINA scores and log(IC 50 ) is equal to − 0.16 thus showing that both endpoints presumably capture different aspects of structural features allowing compounds to be active. Therefore, we normalized values of both endpoints to the same interval and used the average of the normalized values as the final score for the molecules. A new training dataset was formed from the original data and highly-scored putative ligands from Step 2, keeping the ratio of known and generated ligands 1:1. As in step 1, all SMILES were augmented.
The SGNN model was retrained on this new dataset. The sampling temperature was increased according to the formula, as discussed in the Results and Discussion section:
Steps 2-5 were repeated by generating new SMILES at the end of each cycle. In this study, we performed two separate runs for tuning the generator. The first run (run-1) used the VINA score and IC 50 values to select promising inhibitors. The second run (run-2) utilized additional solubility values. Note, additional filters decrease the number of generated molecules, and for chemical space exploration, one needs to increase the number of attempts while generating compounds. In run-2, we generated ten times more SMILES compared to run-1.
Virtual screening
To perform virtual screening of the output of the Generator (run-1), a pharmacophore model was built by Schrödinger Phase [62, 63] based on the known small-molecule Mdmx inhibitor WK298 [64] , which formed a complex with Mdmx. The structure of this complex was obtained by docking WK298 into Mdmx. The initial conformations of WK298 and Mdmx for docking were extracted respectively from crystal structures with PDB IDs of 3lbj [65] and 3dab [54] . The top-scored binding pose was well superimposed with the crystal structure of WK298-Mdmx complex and when it was aligned with the crystal structure of p53-Mdmx complex, we can see WK298 binds to Mdmx in a way that mimics parts of the binding of the native p53 peptide. The Trp23 pocket is filled with the 6-chloroindole substituent and the 4-chlorobenzyl ring protrudes the Leu26 pocket. Finally the third key substituent of WK298, the phenyl ring, occupies the Phe19 pocket, although the plane of this ring is nearly perpendicular to the plane of the Phe19 side chain of p53. The pharmacophore model, Fig. 3 , was based on the aforementioned critical residues of p53 (Phe19, Trp23, and Leu26) [65] . The model was validated internally in Schrödinger suite. Hereby, 204 of 274 active compounds have been successfully retrieved and the parameters are Area Under the Curve (AUC) 0.72, EF1% 10.62. We used this pharmacophore model to screen all the stereoisomers from MD simulations were performed with AmberTools18 [66] , including ligand reduction with Reduce; atomic charge calculation with Antechamber and am1bcc as the backend; topology and coordinate files generation with tleap. Each MD simulation ran for 10 ns of production time under the NPT ensemble referring to the constant 0.987 atm with isotropic position scaling and 300 K using the weak-coupling and SHAKE algorithm; maximum time step of 2 fs was used. The default value of the nonbonded cutoff was used properly along with the Particle Mesh Ewald (PME) calculations. For the stable ones which have a small standard deviation of RMSD value ("sd" in Table 3 ), we further calculated the binding free energies between the protein and ligands using the MMPBSA.py Python script [67] provided by AmberTools18. It is known that post-processing trajectories according to Molecular Mechanics/Poisson Boltzmann (or Generalized Born) Surface Area (MM/PB(GB)SA) approximation allows a better evaluation of the binding patterns of these ligands to Mdmx and, therefore, can help to identify the most potent hits [68] . We selected 100 frames from the last nanosecond of simulation with 10 ps intervals for calculation of ΔG values. The ΔG calculation was not refined by the entropy contribution in order to reduce the computational time. Therefore, the calculated ΔG was only an approximation of true free energy but could be used to compare the generated ligands with similar Mdmx binding pattern.
The parameters and the environment for MD simulations worked well on the WK298-Mdmx complex. We were able to get stable trajectories by running 10 ns MD simulations on this complex, according to the RMSD (see Supporting information).
Results and Discussion
The generator
We examined the ability of the Generator to produce chemical structures following a comparison of distributions for molecular weight, lipophilicity, topological surface area, and synthetic accessibility introduced in [8] . For this purpose, we sampled approximately ten millions SMILES from the Table 3 . The results in Fig. 4 (blue dotted and solid lines labeled with "ChEMBL" and "ChEMBL (generated)") showed a good correlation between distribution shapes for different properties. Notably, our generator sampled 13.2% valid molecules with chiral centers, and 9.5% geometric isomers with cis/ trans configurations.
The Mdmx transfer dataset of known inhibitors consisted of 293 molecules. It was augmented to 2916 SMILES and then used for retraining the original ChEMBL model. While an early-stopping technique was not required for training using ChEMBL, it was essential on this step because the number of parameters of the model was huge compared to the amount of training data, and the model could easily overfit [69] . In our experiments, 3-4 epochs were sufficient for transfer of the information. Total 5803 (run-1) valid . 6 The scheme of the virtual screening workflow SMILES that passed drug-like Lilly filters were generated during all 10 cycles of tuning and 778 with VINA score less than − 7.5 were selected for further virtual screening. The visualization of the chemical space of generated inhibitors, Fig. 5 , based on the deep neural network model [70] reveals an interesting landscape consisting of a valley with the known WK298 inhibitor in the middle and two ridges. Most of compounds selected by MD simulations are located at the highest and most occupied ridge to the left of the valley. The landscape evidently shows that the generator explored particular directions in the vast chemical space, and it was not a pure random walk.
The temperature, Eq. 1, can control the diversity of the generated SMILES. At low T, the system can produce valid compounds similar to the training set and with excellent quality. But to design new creative molecules, we need to add curiosity to the generator by increasing T. The increase of temperature decreased the number of valid SMILES which was 66% for T = 1.45, see Supporting Information. This higher temperature would cause the generator to produce garbage more in more than 1/3 of the outputs. In this study we made 10 such cycles and the corresponding maximum temperature was T = 1.45. The authors [48] used 5-12 cycles for a similar procedure using uniqueness of generated SMILES and their distance to the original dataset as a stopping criteria.
Mdmx inhibitors
The 5803 molecules, which passed advanced drug-likeness filters, were produced by the Generator and were ranked according to the sum of normalized VINA scores and log(IC 50 ) values (Fig. 6 ). Then pharmacophore model filtered the top 102 molecules to 96. We simulated Mdmx complexes with these ligands and 50 trajectories were obtained.
To investigate the stability of the ligands' binding pose in the receptor pocket, we analyzed the RMSD values for the ligand of the Mdmx complex. For the known inhibitor WK298, which was subjected to the same process, the standard deviations of RMSD are in the range of 0.317 to [68, 71] . For WK298 with IC 50 value of 19.7 μM [65] , its ΔG exp is around − 6.5 kcal/mol set. Below we analyze five promising hits (Table 4 ) with ΔG exp < − 6.5, which could be thus expected to have a higher activity than WK298. 3,3-Diphenylpropanamide is one of the common substructures among generated molecules, such as compound 100. 4-chlorophenyl is located in the Trp23 pocket. One of the two-phenyl rings occupies the space of Lys24 of p53 and the other one is exposed to the solvent. In the case of compound 34, one phenyl ring is substituted by its bioisosteres like pyrrole and methyl ester. The latter appears more frequently so as to become another common fragment. Here, 4-fluorophenyl mimics Trp23 of p53 and 4-chlorophenyl mimics Phe19. Besides, 1H-pyrrole toward the opposite direction is aligned with Lys24.
Outside the range of filtered molecules, compound 39 with ΔG of − 6.7 kcal/mol also has an ester-substituted two-phenyl "umbrella". Its long straight chain lies across the cleft of the protein and the hydrophobic pocket shrinks significantly to fit around it. In the crystal structure of Mdmx complex with Mdmx selective inhibitor (PDB ID: 6q9y; compound 16, IC 50 of 3.7 μM), we can observe the similar binding conformation [72] . Apart from filling the Trp23 and Leu26 pockets, the remaining phenyl group nicely overlaps with Ser20 of p53 ( Fig. 7) .
Compound 92 has a unique scaffold that is 3,5-disubstituted-2-thioxo-2,3-dihydro-1H-imidazole. We aligned its Mdmx complex with the crystal structure of p53-Mdmx complex (PDB ID: 3dab). As shown in Fig. 8c , its urea group points towards the indole ring of the p53 residue Trp23 and both of its imino groups have H-bond interaction with Met32. 3-phenyl is fairly close to Phe19 pocket. The three aromatic rings of it lay on the top of helix α2 of Mdmx and the imino group has H-bond interaction with His33. Moreover, Tyr78 of Mdmx kept the "closed" conformation, which was specially studied in [65] .
Comparing the binding pattern of these complexes, the molecule's extremities can be well aligned to Phe19, Trp23 and Leu26 of p53. It is frequently seen that fragments of ligands insert into the Trp23 hydrophobic pocket. Simultaneously, the pocket shrinks to accommodate the size of small molecules. Interestingly, almost every compound analyzed can mimic the three key interacting residues. And some of them can better align with p53 in more residues beyond those three. Especially the surface over the helix α2 is a hot spot for fragments to occupy like Ser20 of p53. As for Tyr78, in most cases, it remains in a "closed conformation" pointing to the ligand. Therefore, we assume it tends to interact with the ligand and flips only with the movement of the ligand. To select some of them that are typical and very different from known Mdmx inhibitors and test them by bioassay in the future would be a worthwhile endeavor. It is noted that some compounds with good ΔG values are not similarly ordered at the top of the results from Generator. This is due to their different computational principles. The scoring function integrates both empirical information and experimental affinity measurements. Relative ΔG in this work is calculated based on molecular mechanics and Poisson-Boltzmann Surface Area (MM/PBSA) in the absence of entropic contribution. And the evaluation criteria of the Generator also equivalently take the predicted IC 50 values into account. 
Constraints during tuning
The current implementation of the tuning workflow for the generator allows introducing several constraints to take into account while generating new molecules. In this study, we used the IC 50 model to estimate the inhibition potential of a compound, and VINA scores to measure its binding affinity. However, most of the generated compounds have solubility issues. We investigated is it possible to create new inhibitors considering solubility as well as other endpoints. We started another cycle of generation but with an additional solubility filter (run-2).
Distributions of the Tanimoto similarity of genenerated molecules for entire compounds and Murcko scaffolds [73] are depicted in Fig. 9 . The first TOP-500 compounds from the second run are also available in the Supporting Information. It is clear that adding another filter shifts the generator to produce a more diverse set of compounds as well as chemical scaffolds. Utilizing more QSAR filters at this stage should benefit the entire de-novo design pipeline and we will further investigate the mutual influences of different filters to the overall scoring procedure.
As shown in Fig. 10 , the overlap between generated compounds during two different runs is less than 10% (517/6395). Note, the total number of generated compounds also includes those structures that overlap with the training dataset. For example, for run-1 the generator produced in total 6395 structures, but 592 of them were already in the training dataset (the generator can produce the same molecule more than one time). Thus, different filters guide exploration of different regions of chemical space and can be used complementary to each other. But the question of how to account for all these filters in one workflow remains open.
Conclusions
Designing putative inhibitors for Mdmx is a challenging task, which so far has not resulted in a new drug candidate. In this work, we exploited the SGNN guided sampling, with docking scores to design new, putative inhibitors of Mdmx. The validation of the focused library generated by the computer through molecular dynamics simulation identified several compounds with binding energies similar or higher than the reference inhibitor. The overall approach being entirely artificial intelligence driven until the final inspection of the binding poses proved its ability, at least virtually, to design new compounds with machine learning methods and validate them with traditional molecular dynamics simulations in an automated manner. Despite several proposed generators [8-13, 48, 74-76] , our study is the first one to describe and implement the full process of virtual drug design of molecules using "generators". The public availability of its code and whole workflow allows other users to adapt and use it for their own projects. Though the number and quality of filters applied during the generation phase are to be optimized further, the whole algorithmic scheme, we believe, will guide future drug-development process, bring new drug candidates for challenging targets and will contribute to the diversification of medicinal chemistry methodology.
